Compare CAL & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAL | IPSC |
|---|---|---|
| Founded | 1878 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.3M | 399.0M |
| IPO Year | 1994 | 2021 |
| Metric | CAL | IPSC |
|---|---|---|
| Price | $13.19 | $2.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $15.00 | $4.25 |
| AVG Volume (30 Days) | 528.2K | ★ 1.1M |
| Earning Date | 05-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | N/A | ★ 91.30 |
| EPS | N/A | ★ N/A |
| Revenue | $85,513,000.00 | ★ $109,164,000.00 |
| Revenue This Year | $5.19 | N/A |
| Revenue Next Year | $2.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.46 | ★ 1556.76 |
| 52 Week Low | $8.80 | $0.44 |
| 52 Week High | $17.53 | $2.97 |
| Indicator | CAL | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 45.81 |
| Support Level | $12.80 | $1.87 |
| Resistance Level | $13.55 | $2.67 |
| Average True Range (ATR) | 0.57 | 0.16 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 32.63 | 8.16 |
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.